The global infection prevention product and services market is estimated to increase at a CAGR of 5.41% from a market size of USD113.048 billion in 2019 to a market size of USD155.079 billion by the end of 2025.With the world suffering from the sudden onset of coronavirus pandemic, the healthcare companies are geared for the manufacturing of face masks to prevent from human-to-human transmission. Also, with the worldwide usage of these protective masks, there have been shortage issues as well, hence, this is further pressurizing the medical companies to speed up their manufacturing in order to keep pace with the current high demand. However, this seems quite a burden, but the demand for this protective equipment among other personal protection supplies are at peak in the present, and this is projected to continue to remain throughout in 2020, thus, surging the market demand for personal protective equipment.
Furthermore, the growing number of acute and chronic diseases are further propelling the market growth in the forecast period. Chronic diseases include cardiovascular diseases, prevalence of cancer, asthma, and COPD among others. Concerns regarding hospital-associated infections, surgical-site infections, and medical waste disposal are providing an opportunity for the market to grow rapidly in the forecast period and in the coming years.
On the basis of Geography, North America is estimated to hold a significant market share with the presence of advanced health facilities, hence, efforts are made for maintaining these facilities with an emphasis on infection prevention and control. Additionally, the presence of big market players in the region is further burgeoning the market demand in the forecast period and in the coming years. On the other hand, the Asia Pacific region is accounted to be the fastest-growing, due to the high prevalence of chronic diseases in the region demanding treatments. Also, with the highest number of geriatric populations in Japan, the APAC region holds strong growth prospects for the market to grow at a significant pace in the forecast period.
Furthermore, the booming medical tourism industry and the growing number of surgeries along with the minimally invasive and robotic surgeries are further propelling the market demand in the forecast period.
Strict recommendation from the World Health Organization (WHO) for people who are in close contact with the infected or confirmed COVID 19 cases to wear personal protective equipment (PPE) is propagating the market growth at present.
At present, there are no vaccines for protection against COVID 19, hence, it becomes necessary to minimize risk exposure to the virus. The World Health Organization recommendations, especially for people who are in close contact with the infected or confirmed cases are driving the market demand.
These recommendations suggest the use of personal protective equipment for prevention from further spreading of the disease. There are certain guidelines for the selection of PPE, the guidelines are based on January 2020 guidance which is published by WHO, the European Center for Disease Prevention and Control (ECDC), and the U.S. Centers for Disease Control and Prevention (CDC).
For the selection of right PPE, the following standards are to be followed, this includes, EN 455 + ASTM D6319 + ASTM D3578 for gloves used for medical examinations and surgical procedures, EN ISO 374-5 VIRUS and ASTM F1671 for hand and body protection against chemicals and microorganisms’ risks. EN 14126 for protective clothing against infectious diseases, and EN 149:2001 and AI:2009 for respiratory tract protection for air-borne particulates.
The prevalence of healthcare services is further providing an opportunity for the infection prevention product and services market to thrive in the forecast period and in the upcoming years.
Healthcare services categorized as Primary care, Secondary care, Tertiary care, and Quaternary care are also driving the market demand during the forecast period. Primary care involves healthcare professionals who play a role in a local community. This provides care to patients of all ages, different socio-economic and of different geographic regions. Various chronic illnesses can be treated under primary care including hypertension, diabetes, depression, and anxiety. The professionals involved in primary care would be usually a general practitioner or a family doctor. Other professionals include nurses or physiotherapists. The key characteristic of primary care is the continuity consisting of routine check-ups and preventive care. Depending on the patient’s condition he/she may be advised for secondary or tertiary care. Secondary care includes treatment of serious illnesses that require immediate action and is for a shorter period of time. One can find this kind of facility in the hospital’s emergency department which requires skilled professionals and attendants. Tertiary care is for specialized healthcare services. The personnel are referred via primary and secondary care and require advanced medical investigation and treatment facilities. Examples include cardiac and other complex surgeries. Quaternary care is an extension of the tertiary care and makes use of advanced and highly specialized treatments and care. These are not widely accessible but still provides a favourable growth opportunity for the market to proliferate in the forecast period.
The presence of the geriatric population in the world is projected to drive the market demand in the forecast period.
The growing geriatric population has given rise to an increase in healthcare costs to be required for the treatment of non-communicable diseases and chronic diseases related to old age.
Population aging and growth at advanced stages, above 65 years of age, is giving rise to concerns such as pressure on health systems which needs to adapt in order to meet the growing demands for care, services and technologies for the prevention and the treatment of the age-associated non-communicable and chronic diseases. Also, as the non-communicable diseases and the potential economic & societal costs of these non-communicable diseases rise with age, they have the ability to affect economic growth as well. Hence, the growing geriatric population has a high impact on the growth of the global infection prevention product and services market over the next five years. With the increasing elderly population, there is a significant increase in the home healthcare services as well, thus, this is further surging the market growth in the upcoming years.